Результати пошуку - Marcel Teichert
- Показ 1 - 2 результатів із 2
-
1
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study за авторством Maximilian Merz, Anca‐Maria Albici, Bastian von Tresckow, Kristin Rathje, Roland Fenk, Tobias A.W. Holderried, Fabian Müller, Natalia Tovar, Aina Oliver‐Cáldes, Vladan Vučinić, Soraya Kharboutli, Ben‐Niklas Bärmann, Francis Ayuk, Uwe Platzbecker, Friedrich Stölzel, Nathalie Schub, Friederike Schmitz, David Fandrei, Patrick Born, Cyrus Khandanpour, Christine Hanoun, Keven Hörster, Marcel Teichert, Barbara Jeker, Michèle J. Hoffmann, Nicolaus Kröger, Carlos Fernández de Larrea, Thomas Pabst, Nico Gagelmann
Опубліковано 2025Artigo -
2
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy за авторством Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel, Tobias A.W. Holderried, Roland Fenk, Fabian Müller, Natalia Tovar, Aina Oliver‐Cáldes, Kristin Rathje, James A. Davis, David Fandrei, Vladan Vučinić, Soraya Kharboutli, Ben‐Niklas Baermann, Francis Ayuk, Uwe Platzbecker, Anca‐Maria Albici, Nathalie Schub, Friederike Schmitz, Leyla Shune, Jack Khouri, Faiz Anwer, Shahzad Raza, Joseph P. McGuirk, Zahra Mahmoudjafari, Kimberly Green, Cyrus Khandanpour, Marcel Teichert, Barbara Jeker, Michèle J. Hoffmann, Nicolaus Kröger, Bastian von Tresckow, Carlos Fernández de Larrea, Thomas Pabst, Al‐Ola Abdallah, Nico Gagelmann
Опубліковано 2024Artigo
Інструменти для пошуку:
Пов'язані теми
Internal medicine
Medicine
Multiple myeloma
Oncology
Antibody
Biology
Bortezomib
CD34
CD38
Cancer
Chemotherapy
Chimeric antigen receptor
Daratumumab
Genetics
Immunology
Immunotherapy
Materials science
Metallurgy
Multicenter study
Randomized controlled trial
Refractory (planetary science)
Salvage therapy
Stem cell